August 02, 2022
Oxford, UK and Cleveland, Ohio, USA – The Oxford-Harrington Rare Disease Centre (OHC), a partnership of the University of Oxford and Harrington Discovery Institute at University Hospitals in Cleveland, Ohio, today announced its support of a novel treatment for Duchenne muscular dystrophy, a rare neuromuscular disease...
Continue ReadingJanuary 18, 2018
January 18, 2018, Cleveland, Ohio – The Harrington Discovery Institute at University Hospitals in Cleveland, Ohio, today announced the 2018 Harrington Scholar-Innovator Award recipients. The awards support breakthrough discoveries in diverse research areas including cancer, diabetes, osteoporosis, and addiction.The Harrington... Continue Reading
September 01, 2017
Formed by BioMotiv and University of PittsburghCLEVELAND AND PITTSBURGH — SEPTEMBER 21, 2017 — BioMotiv, a drug development accelerator associated with The Harrington Project for Discovery & Development, and the University of Pittsburgh, are announcing the formation of a new biotechnology startup, Koutif Therapeutics, which... Continue Reading
August 01, 2017
Cleveland – The National Center for Excellence in Fighting Blindness, a Gund-Harrington Initiative, has opened its fourth annual Gund-Harrington Scholar Award competition to support innovative research efforts that seek to prevent, treat or cure blindness.The Gund-Harrington Initiative is a collaboration between Foundation... Continue Reading
June 07, 2017
CLEVELAND – Harrington Discovery Institute at University Hospitals in Cleveland, Ohio part of The Harrington Project for Discovery & Development, and the Foundation Fighting Blindness have announced their 2017 Gund-Harrington Scholars.Harrington Discovery Institute partnerships are based on a shared mission to advance... Continue Reading
May 24, 2017
Cleveland, Ohio, USA –May 24, 2017 – Harrington Discovery Institute at University Hospitals in Cleveland, Ohio – part of The Harrington Project for Discovery & Development – is pleased to announce its request for proposals for the Harrington Rare Disease Scholar Award. The Harrington Rare Disease Scholar Award supports... Continue Reading
May 04, 2017
CLEVELAND (May 4, 2017) – National and international nominations are being sought for the fifth annual Harrington Prize for Innovation in Medicine, which honors a physician-scientist who has moved science forward with achievements notable for innovation, creativity and the potential for clinical application. Deadline for... Continue Reading
April 27, 2017
Takeda and Harrington Discovery Institute at University Hospitals Announce a Collaboration to Advance the Development of Rare Disease TherapeuticsOsaka, Japan and Cleveland, Ohio, USA – 27 April 2017 – Takeda Pharmaceutical Company Limited (TSE: 4502), and Harrington Discovery Institute at University Hospitals in Cleveland... Continue Reading
March 14, 2017
CLEVELAND – The fourth annual Harrington Prize for Innovation in Medicine has been jointly awarded to Daniel J. Drucker, MD (Mount Sinai Hospital, Canada), Joel F. Habener, MD (Massachusetts General Hospital, USA) and Jens J. Holst, MD, DMSc (University of Copenhagen, Denmark) for their discovery of incretin hormones and for... Continue Reading
February 09, 2017
Cleveland, Ohio – Harrington Discovery Institute at University Hospitals (UH) in Cleveland, Ohio – part of The Harrington Project for Discovery & Development – has opened its annual award competition to fund physician-scientist innovators at major academic medical centers across the country to advance their work toward... Continue Reading
January 24, 2017
CLEVELAND: Two internationally recognized medical research leaders from University Hospitals Cleveland Medical Center and Case Western Reserve University School of Medicine have received Outstanding Investigator Awards from the National Institutes of Health (NIH). The 7-year, $6.7 million dollar awards, which are the highest... Continue Reading